J. Craig Venter, the biologist who challenged the scientific establishment with his rapid, private-sector assault on the human genome, has died at the age of 79. A former surfer and Vietnam veteran turned medical researcher, Venter combined a brilliant scientific mind with the single-minded drive of an entrepreneur. According to The New York Times, he was a “risk-taking outsider” who “brought speed, competition and controversy to one of science’s biggest races” – the quest to decode the human genome.
The genome race rivalry
Having decided in the 1990s that the US government’s $3 billion Human Genome Project (HGP) was moving at a snail’s pace, Venter took the gamble that “he could enter the race late and beat it with a much faster method”. He launched a private company, Celera Genomics, as his vehicle. The competition was intense, with Venter often described as “the alpha male of US science”, noted the Financial Times in 2007. Critics nicknamed him “Darth Venter” and demonised him, according to The Telegraph. Venter relished the controversy – “flashing his Learjet, yacht and Rolex, and his ability to raise $1 billion on the New York stock market in a single day” when he floated Celera in February 2000 at the height of the biotechnology boom. The scramble ended in a photo finish, with the two sides jointly announcing their success at a press conference presided over by Bill Clinton in 2000. Crucially, by publishing the full sequence, the HGP undermined Venter’s plans to register patent rights.
Shotgun sequencing: a revolutionary method
Celera pioneered a technique called “shotgun sequencing”, which was faster and cheaper than the HGP’s method. According to Chemistry World, the idea was to randomly cut up the genome into fragments, sequence them, and then use a supercomputer to work out how the pieces related to one another. In contrast, the HGP’s approach involved slogging systematically through the genome. The method, now known as whole genome shotgun sequencing, significantly reduced the time and cost of sequencing. Indeed, the privately backed company took two years to achieve what the HGP had been trying to do for 14 years, The Times reported. Celera’s genome sequence was published in Science the day after the HGP’s publication in Nature. Venter is credited with developing the shotgun sequencing method, which not only accelerated the Human Genome Project but also made its results freely available, expanding medical research.
Controversy and later ventures
J. Craig Venter was not an easy man to work with, says Chemistry World. Just over a year after his human genome coup, he was fired by Celera because of internal conflicts. He continued to drive genome sequencing forward via a new non-profit, the J. Craig Venter Institute (JCVI), founded in 2006. In 2010, Venter and his team at JCVI created the world’s first synthetic bacterial cell, controlled by a chemically synthesised genome. This achievement demonstrated that genomes could be designed digitally and constructed from chemical components. He also co-founded Synthetic Genomics, Inc. (now Viridos), to advance technologies in vaccines, biofuels and medicines. In 2013, he co-founded Human Longevity Inc. (HLI), a company focused on using genomic sequencing for long-term health assessment. However, his tenure at HLI was marked by controversy; the company later sued the J. Craig Venter Institute, The Times reported, “over allegations that he pilfered its trade secrets, poached its staff and sought to lure away its investors”. The lawsuit was eventually dismissed. Venter himself was diagnosed with prostate cancer in 2016.
Legacy and recognition
By the time of his death, Venter was worth tens of millions of dollars. But he missed out on the bonanza that synthetic biology now promises in “myriad applications”, according to The Telegraph. Born in Salt Lake City, Utah, on October 14, 1946, into a military family and brought up in Millbrae, California, he was an unruly youth who dropped out of high school to become a surfer before serving in the US Navy during the Vietnam War. His experiences at the Da Nang hospital reportedly sparked his interest in medical research. He later earned a Bachelor of Science in biochemistry and a PhD in physiology and pharmacology from the University of California, San Diego, and became a professor at the State University of New York at Buffalo and the Roswell Park Cancer Institute. He co-founded the non-profit Institute for Genomic Research with his then-wife, genomicist Claire Fraser.
Venter’s contributions were recognised with numerous awards, including the US National Medal of Science in 2008, the Gairdner Foundation International Award in 2002, and the Paul Ehrlich and Ludwig Darmstaedter Prize in 2001. He was listed among Time magazine’s 100 most influential people in 2007 and 2008. He was a prolific author, with works including “A Life Decoded: My Genome: My Life” and “Life at the Speed of Light.” Venter died in San Diego, California, on April 29, 2026, following a brief hospitalisation due to complications from recently diagnosed cancer treatment. Maverick to the end, he was regarded by detractors as an “opportunistic maniac” – and by admirers as a plucky “genius” who challenged the research establishment and “should have been given a Nobel Prize”.
